CompletedNCT02575183
Varenicline for Waterpipe Smoking Cessation
About this title
Read the official source — NCT02575183Medication studyAges 18+LebanonAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Beirut and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: August 31, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 152
- Sponsor
- American University of Beirut Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Lebanon
- Age range
- Over 18 Years
- Official registry ID
- NCT02575183
- Official title
Show the full official title
Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Beirut
Questions about this study
Who is behind this study?
The study sponsor is American University of Beirut Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Varinecline (Chantix) and Placebo (for Varenicline).
Who was this study for?
Listed age limits: from 18 years.
